Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35,258,614
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
3,302,911
-
Shares change
-
-133,812
-
Total reported value, excl. options
-
$9,050,644
-
Value change
-
-$407,464
-
Put/Call ratio
-
0%
-
Number of buys
-
16
-
Number of sells
-
17
-
Price
-
$2.74
Institutional Holders of Anixa Biosciences, Inc. - Common Stock (ANIX) as of Q1 2022
As of 31 Mar 2022 Anixa Biosciences, Inc. - Common Stock (ANIX) had 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,302,911 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Long Focus Capital Management, LLC, STATE STREET CORP, BlackRock Inc., Bank of New York Mellon Corp, MORGAN STANLEY, and RAYMOND JAMES & ASSOCIATES.
This table shows 37 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.